High expression of ERBB2 is an independent risk factor for reduced recurrence-free survival in patients with stage T1 non-muscle-invasive bladder cancer.
暂无分享,去创建一个
A. Hartmann | H. Taubert | S. Wach | B. Wullich | R. Wirtz | M. Eckstein | D. Sikic | P. Erben | J. Breyer | B. Keck | F. Roghmann | F. Kunath | V. Weyerer | Jennifer Kubon